Gene Therapy Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: GF0E59F9660FEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Gene Therapy Drugs in Global, including the following market information:

Global Gene Therapy Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Gene Therapy Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Neuromuscular Disease Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Gene Therapy Drugs include F. Hoffmann-La Roche AG, Novartis International AG, Gilead Sciences, Inc., Ultragenyx Pharmaceutical?Inc., Applied Genetic Technologies Corp, Audentes Therapeutics, BioMarin Pharmaceutical, Bluebird Bio and Nightstar Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gene Therapy Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gene Therapy Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Gene Therapy Drugs Market Segment Percentages, by Type, 2021 (%)

• Neuromuscular Disease
• Genetic Disease
• Other

Global Gene Therapy Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Gene Therapy Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Pharmacy

Global Gene Therapy Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Gene Therapy Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Gene Therapy Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Gene Therapy Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• F. Hoffmann-La Roche AG
• Novartis International AG
• Gilead Sciences, Inc.
• Ultragenyx Pharmaceutical?Inc.
• Applied Genetic Technologies Corp
• Audentes Therapeutics
• BioMarin Pharmaceutical
• Bluebird Bio
• Nightstar Therapeutics
• Sangamo Therapeutics
• Spark Therapeutics
• uniQure
• VBL Therapeutics
• Voyager Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gene Therapy Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gene Therapy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GENE THERAPY DRUGS OVERALL MARKET SIZE

2.1 Global Gene Therapy Drugs Market Size: 2021 VS 2028
2.2 Global Gene Therapy Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gene Therapy Drugs Players in Global Market
3.2 Top Global Gene Therapy Drugs Companies Ranked by Revenue
3.3 Global Gene Therapy Drugs Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapy Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gene Therapy Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Gene Therapy Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gene Therapy Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Gene Therapy Drugs Market Size Markets, 2021 & 2028
  4.1.2 Neuromuscular Disease
  4.1.3 Genetic Disease
  4.1.4 Other
4.2 By Type - Global Gene Therapy Drugs Revenue & Forecasts
  4.2.1 By Type - Global Gene Therapy Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Gene Therapy Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Gene Therapy Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gene Therapy Drugs Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Pharmacy
5.2 By Application - Global Gene Therapy Drugs Revenue & Forecasts
  5.2.1 By Application - Global Gene Therapy Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Gene Therapy Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Gene Therapy Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Gene Therapy Drugs Market Size, 2021 & 2028
6.2 By Region - Global Gene Therapy Drugs Revenue & Forecasts
  6.2.1 By Region - Global Gene Therapy Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Gene Therapy Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Gene Therapy Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Gene Therapy Drugs Revenue, 2017-2028
  6.3.2 US Gene Therapy Drugs Market Size, 2017-2028
  6.3.3 Canada Gene Therapy Drugs Market Size, 2017-2028
  6.3.4 Mexico Gene Therapy Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Gene Therapy Drugs Revenue, 2017-2028
  6.4.2 Germany Gene Therapy Drugs Market Size, 2017-2028
  6.4.3 France Gene Therapy Drugs Market Size, 2017-2028
  6.4.4 U.K. Gene Therapy Drugs Market Size, 2017-2028
  6.4.5 Italy Gene Therapy Drugs Market Size, 2017-2028
  6.4.6 Russia Gene Therapy Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Gene Therapy Drugs Market Size, 2017-2028
  6.4.8 Benelux Gene Therapy Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Gene Therapy Drugs Revenue, 2017-2028
  6.5.2 China Gene Therapy Drugs Market Size, 2017-2028
  6.5.3 Japan Gene Therapy Drugs Market Size, 2017-2028
  6.5.4 South Korea Gene Therapy Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Gene Therapy Drugs Market Size, 2017-2028
  6.5.6 India Gene Therapy Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Gene Therapy Drugs Revenue, 2017-2028
  6.6.2 Brazil Gene Therapy Drugs Market Size, 2017-2028
  6.6.3 Argentina Gene Therapy Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gene Therapy Drugs Revenue, 2017-2028
  6.7.2 Turkey Gene Therapy Drugs Market Size, 2017-2028
  6.7.3 Israel Gene Therapy Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Gene Therapy Drugs Market Size, 2017-2028
  6.7.5 UAE Gene Therapy Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 F. Hoffmann-La Roche AG
  7.1.1 F. Hoffmann-La Roche AG Corporate Summary
  7.1.2 F. Hoffmann-La Roche AG Business Overview
  7.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Major Product Offerings
  7.1.4 F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue in Global Market (2017-2022)
  7.1.5 F. Hoffmann-La Roche AG Key News
7.2 Novartis International AG
  7.2.1 Novartis International AG Corporate Summary
  7.2.2 Novartis International AG Business Overview
  7.2.3 Novartis International AG Gene Therapy Drugs Major Product Offerings
  7.2.4 Novartis International AG Gene Therapy Drugs Revenue in Global Market (2017-2022)
  7.2.5 Novartis International AG Key News
7.3 Gilead Sciences, Inc.
  7.3.1 Gilead Sciences, Inc. Corporate Summary
  7.3.2 Gilead Sciences, Inc. Business Overview
  7.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Major Product Offerings
  7.3.4 Gilead Sciences, Inc. Gene Therapy Drugs Revenue in Global Market (2017-2022)
  7.3.5 Gilead Sciences, Inc. Key News
7.4 Ultragenyx Pharmaceutical?Inc.
  7.4.1 Ultragenyx Pharmaceutical?Inc. Corporate Summary
  7.4.2 Ultragenyx Pharmaceutical?Inc. Business Overview
  7.4.3 Ultragenyx Pharmaceutical?Inc. Gene Therapy Drugs Major Product Offerings
  7.4.4 Ultragenyx Pharmaceutical?Inc. Gene Therapy Drugs Revenue in Global Market (2017-2022)
  7.4.5 Ultragenyx Pharmaceutical?Inc. Key News
7.5 Applied Genetic Technologies Corp
  7.5.1 Applied Genetic Technologies Corp Corporate Summary
  7.5.2 Applied Genetic Technologies Corp Business Overview
  7.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Major Product Offerings
  7.5.4 Applied Genetic Technologies Corp Gene Therapy Drugs Revenue in Global Market (2017-2022)
  7.5.5 Applied Genetic Technologies Corp Key News
7.6 Audentes Therapeutics
  7.6.1 Audentes Therapeutics Corporate Summary
  7.6.2 Audentes Therapeutics Business Overview
  7.6.3 Audentes Therapeutics Gene Therapy Drugs Major Product Offerings
  7.6.4 Audentes Therapeutics Gene Therapy Drugs Revenue in Global Market (2017-2022)
  7.6.5 Audentes Therapeutics Key News
7.7 BioMarin Pharmaceutical
  7.7.1 BioMarin Pharmaceutical Corporate Summary
  7.7.2 BioMarin Pharmaceutical Business Overview
  7.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Major Product Offerings
  7.7.4 BioMarin Pharmaceutical Gene Therapy Drugs Revenue in Global Market (2017-2022)
  7.7.5 BioMarin Pharmaceutical Key News
7.8 Bluebird Bio
  7.8.1 Bluebird Bio Corporate Summary
  7.8.2 Bluebird Bio Business Overview
  7.8.3 Bluebird Bio Gene Therapy Drugs Major Product Offerings
  7.8.4 Bluebird Bio Gene Therapy Drugs Revenue in Global Market (2017-2022)
  7.8.5 Bluebird Bio Key News
7.9 Nightstar Therapeutics
  7.9.1 Nightstar Therapeutics Corporate Summary
  7.9.2 Nightstar Therapeutics Business Overview
  7.9.3 Nightstar Therapeutics Gene Therapy Drugs Major Product Offerings
  7.9.4 Nightstar Therapeutics Gene Therapy Drugs Revenue in Global Market (2017-2022)
  7.9.5 Nightstar Therapeutics Key News
7.10 Sangamo Therapeutics
  7.10.1 Sangamo Therapeutics Corporate Summary
  7.10.2 Sangamo Therapeutics Business Overview
  7.10.3 Sangamo Therapeutics Gene Therapy Drugs Major Product Offerings
  7.10.4 Sangamo Therapeutics Gene Therapy Drugs Revenue in Global Market (2017-2022)
  7.10.5 Sangamo Therapeutics Key News
7.11 Spark Therapeutics
  7.11.1 Spark Therapeutics Corporate Summary
  7.11.2 Spark Therapeutics Business Overview
  7.11.3 Spark Therapeutics Gene Therapy Drugs Major Product Offerings
  7.11.4 Spark Therapeutics Gene Therapy Drugs Revenue in Global Market (2017-2022)
  7.11.5 Spark Therapeutics Key News
7.12 uniQure
  7.12.1 uniQure Corporate Summary
  7.12.2 uniQure Business Overview
  7.12.3 uniQure Gene Therapy Drugs Major Product Offerings
  7.12.4 uniQure Gene Therapy Drugs Revenue in Global Market (2017-2022)
  7.12.5 uniQure Key News
7.13 VBL Therapeutics
  7.13.1 VBL Therapeutics Corporate Summary
  7.13.2 VBL Therapeutics Business Overview
  7.13.3 VBL Therapeutics Gene Therapy Drugs Major Product Offerings
  7.13.4 VBL Therapeutics Gene Therapy Drugs Revenue in Global Market (2017-2022)
  7.13.5 VBL Therapeutics Key News
7.14 Voyager Therapeutics
  7.14.1 Voyager Therapeutics Corporate Summary
  7.14.2 Voyager Therapeutics Business Overview
  7.14.3 Voyager Therapeutics Gene Therapy Drugs Major Product Offerings
  7.14.4 Voyager Therapeutics Gene Therapy Drugs Revenue in Global Market (2017-2022)
  7.14.5 Voyager Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Gene Therapy Drugs Market Opportunities & Trends in Global Market
Table 2. Gene Therapy Drugs Market Drivers in Global Market
Table 3. Gene Therapy Drugs Market Restraints in Global Market
Table 4. Key Players of Gene Therapy Drugs in Global Market
Table 5. Top Gene Therapy Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Gene Therapy Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Gene Therapy Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Gene Therapy Drugs Product Type
Table 9. List of Global Tier 1 Gene Therapy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gene Therapy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Gene Therapy Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Gene Therapy Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Gene Therapy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Gene Therapy Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Gene Therapy Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Gene Therapy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Gene Therapy Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Gene Therapy Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Gene Therapy Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Gene Therapy Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Gene Therapy Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Gene Therapy Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Gene Therapy Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Gene Therapy Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Gene Therapy Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Gene Therapy Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Gene Therapy Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Gene Therapy Drugs Revenue, (US$, Mn), 2023-2028
Table 30. F. Hoffmann-La Roche AG Corporate Summary
Table 31. F. Hoffmann-La Roche AG Gene Therapy Drugs Product Offerings
Table 32. F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Novartis International AG Corporate Summary
Table 34. Novartis International AG Gene Therapy Drugs Product Offerings
Table 35. Novartis International AG Gene Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Gilead Sciences, Inc. Corporate Summary
Table 37. Gilead Sciences, Inc. Gene Therapy Drugs Product Offerings
Table 38. Gilead Sciences, Inc. Gene Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Ultragenyx Pharmaceutical?Inc. Corporate Summary
Table 40. Ultragenyx Pharmaceutical?Inc. Gene Therapy Drugs Product Offerings
Table 41. Ultragenyx Pharmaceutical?Inc. Gene Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Applied Genetic Technologies Corp Corporate Summary
Table 43. Applied Genetic Technologies Corp Gene Therapy Drugs Product Offerings
Table 44. Applied Genetic Technologies Corp Gene Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Audentes Therapeutics Corporate Summary
Table 46. Audentes Therapeutics Gene Therapy Drugs Product Offerings
Table 47. Audentes Therapeutics Gene Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 48. BioMarin Pharmaceutical Corporate Summary
Table 49. BioMarin Pharmaceutical Gene Therapy Drugs Product Offerings
Table 50. BioMarin Pharmaceutical Gene Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Bluebird Bio Corporate Summary
Table 52. Bluebird Bio Gene Therapy Drugs Product Offerings
Table 53. Bluebird Bio Gene Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Nightstar Therapeutics Corporate Summary
Table 55. Nightstar Therapeutics Gene Therapy Drugs Product Offerings
Table 56. Nightstar Therapeutics Gene Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Sangamo Therapeutics Corporate Summary
Table 58. Sangamo Therapeutics Gene Therapy Drugs Product Offerings
Table 59. Sangamo Therapeutics Gene Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Spark Therapeutics Corporate Summary
Table 61. Spark Therapeutics Gene Therapy Drugs Product Offerings
Table 62. Spark Therapeutics Gene Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 63. uniQure Corporate Summary
Table 64. uniQure Gene Therapy Drugs Product Offerings
Table 65. uniQure Gene Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 66. VBL Therapeutics Corporate Summary
Table 67. VBL Therapeutics Gene Therapy Drugs Product Offerings
Table 68. VBL Therapeutics Gene Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 69. Voyager Therapeutics Corporate Summary
Table 70. Voyager Therapeutics Gene Therapy Drugs Product Offerings
Table 71. Voyager Therapeutics Gene Therapy Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Gene Therapy Drugs Segment by Type in 2021
Figure 2. Gene Therapy Drugs Segment by Application in 2021
Figure 3. Global Gene Therapy Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gene Therapy Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gene Therapy Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Therapy Drugs Revenue in 2021
Figure 8. By Type - Global Gene Therapy Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Gene Therapy Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Gene Therapy Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Gene Therapy Drugs Revenue Market Share, 2017-2028
Figure 12. US Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Gene Therapy Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Gene Therapy Drugs Revenue Market Share, 2017-2028
Figure 24. China Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Gene Therapy Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Gene Therapy Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Gene Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis International AG Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Gilead Sciences, Inc. Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Ultragenyx Pharmaceutical?Inc. Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Applied Genetic Technologies Corp Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Audentes Therapeutics Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. BioMarin Pharmaceutical Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bluebird Bio Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Nightstar Therapeutics Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sangamo Therapeutics Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Spark Therapeutics Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. uniQure Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. VBL Therapeutics Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Voyager Therapeutics Gene Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)